The validity of serologic tests for <i>Trypanosoma cruzi</i> and the effectiveness of transfusional screening strategies in a hyperendemic region

Abstract

Routine blood donor screening for T. cruzi with a single test results in unacceptable numbers of false-negative samples in highly endemic areas or in at risk population groups. Adding a second test seems mandatory, but which one to choose depends on local cost components and feasibility.